A small study on young adults with NAFLD and without a definite GH deficiency, but with suboptimal IGF-1 levels, has not shown any significant impact on ALT, AST, and GGT levels. This evidence concerns the gene IGF1 and metabolic dysfunction-associated steatotic liver disease.